Pharmagen 

$0.000010
5
+$0.00+0% Monday 20:00

Statistics

Day High
0.000001
Day Low
0.000001
52W High
0.00001
52W Low
0.000001
Volume
2,399
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical company that competes with Pharmagen in various therapeutic areas, including vaccines, oncology, and immunology.
Merck
MRK
Mkt Cap366B
Merck operates in similar sectors as Pharmagen, focusing on pharmaceuticals and health solutions, particularly in areas like cancer treatment and vaccines.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson is a diversified healthcare giant that competes with Pharmagen across several segments, including pharmaceuticals, medical devices, and consumer health products.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie competes in the biopharmaceutical field, focusing on treatments for conditions such as rheumatoid arthritis and Crohn's disease, areas where Pharmagen may also be active.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is known for its antiviral drugs for HIV, hepatitis B, hepatitis C, and influenza, competing with Pharmagen in the development and marketing of treatments for infectious diseases.
AMGEN
AMGN
Mkt Cap233.78B
Amgen focuses on human therapeutics and competes with Pharmagen in areas such as oncology and cardiovascular disease.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases, competing with Pharmagen in multiple therapeutic areas.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that competes with Pharmagen by providing solutions in innovative medicines, generics, and biosimilars across a wide range of diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche is a leader in research-focused healthcare with strengths in pharmaceuticals and diagnostics, competing with Pharmagen in areas such as oncology and infectious diseases.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is a global biopharmaceutical company focused on human health, competing with Pharmagen in areas like diabetes, vaccines, and rare diseases.

About

Pharmagen, Inc., a pharmaceutical company located in Silver Spring, Maryland, operates primarily as a distributor within the U.S. healthcare market. It provides a diverse range of specialty drugs to various medical clients, including hospitals, acute care centers, surgical facilities, and other healthcare practitioners nationwide. The company's offerings encompass sourcing and distributing specialty pharmaceuticals, blood plasma derivatives, unique medical products, vaccines, anti-infectives, and often hard-to-find medications. A key area of its expertise lies in plasma derivatives, which are vital for managing severe conditions such as cancer, hemophilia, rheumatoid arthritis, multiple sclerosis, blood disorders, hepatitis, and HIV. Additionally, Pharmagen supplies specialized products designed to treat respiratory, oncological, cardiovascular, and hormonal ailments. Beyond its core distribution activities, Pharmagen also produces and sells its own health supplements, notably Clotamin, an over-the-counter multivitamin formulated specifically for individuals undergoing Warfarin therapy. The company further serves its existing customers by supplying traditional pharmaceuticals, including a variety of antibiotics, vaccines, and other oral and injectable medicines. With a specialized focus on drug formulation, Pharmagen Inc. adopted its current name in January 2013, having previously operated as Sunpeaks Ventures, Inc.
Show more...
CEO
Mackie A. Barch
Employees
24
Country
United States
ISIN
US71715W1062

Listings

0 Comments

Share your thoughts

FAQ

What is Pharmagen stock price today?
The current price of PHRX is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Pharmagen stock price performance more closely on the chart.
What is Pharmagen stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Pharmagen stocks are traded under the ticker PHRX.
Is Pharmagen stock price growing?
PHRX stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Pharmagen has showed a +0% increase.
What were Pharmagen earnings last quarter?
PHRX earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Pharmagen have?
As of September 04, 2026, the company has 24 employees.
In which sector is Pharmagen located?
Pharmagen operates in the Health & Wellness sector.
When did Pharmagen complete a stock split?
Pharmagen has not had any recent stock splits.
Where is Pharmagen headquartered?
Pharmagen is headquartered in Silver Spring, United States.